PT  - JOURNAL ARTICLE
AU  - Ciupe, Stanca M.
AU  - Tuncer, Necibe
TI  - Identifiability of parameters in mathematical models of SARS-CoV-2 infections in humans
AID  - 10.1101/2022.04.26.22274345
DP  - 2022 Jan 01
TA  - medRxiv
PG  - 2022.04.26.22274345
4099  - http://medrxiv.org/content/early/2022/04/28/2022.04.26.22274345.short
4100  - http://medrxiv.org/content/early/2022/04/28/2022.04.26.22274345.full
AB  - Determining accurate estimates for the characteristics of the severe acute respiratory syndrome coronavirus 2 in the upper and lower respiratory tracts, by fitting mathematical models to data, is made difficult by the lack of measurements early in the infection. To determine the sensitivity of viral predictions to the noise in the data, we developed a novel two-patch within-host mathematical model and investigated its ability to match population level data. We proposed several approaches that can improve practical identifiability of parameters, including an optimal experimental approach, and found that availability of viral data early in the infection is of essence for improving the accuracy of the estimates. Our findings can be useful for designing interventions.Competing Interest StatementThe authors have declared no competing interest.Funding StatementSMC acknowledges support from National Science Foundation grants No. DMS-1813011 and DMS-2051820 and by a Virginia Tech Center for Emerging, Zoonotic, and Arthropod-borne Pathogens (CeZAP) seed grant. NT acknowledges partial support from National Science Foundation grant DMS-1951626.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesCode is available upon request.